OGN:NYSE
Organon & Co
USD 13,90
0,00%
(0,00) 1D
13 Nov., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Mkt. cap
3,65 mjd
Avg. vol.
2,53 m
Volume
628,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Mkt. cap
3,65 mjd
Avg. vol.
2,53 m
Volume
628,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
StreetInsider
·
12 minute gelede
S&P 500, Nasdaq set for lower open as AI stocks feel Nvidia heat
Barron's
·
1 uur gelede
S&P 500 Futures Fall in Premarket Trading; TELUS Corp., Vaxcyte Lead
Investing.com
·
2 uur gelede
Barclays joins Morgan Stanley in seeing S&P 500 at 8,700 by end-2027
FXEmpire
·
50 minute gelede
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com